BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7096564)

  • 1. Immunological cross-reactivity between the alpha-bungarotoxin-binding component from rat brain and nicotinic acetylcholine receptor.
    Wonnacott S; Harrison R; Lunt G
    J Neuroimmunol; 1982 Aug; 3(1):1-13. PubMed ID: 7096564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of monoclonal antibodies to electroplaque acetylcholine receptors with the alpha-bungarotoxin binding site of goldfish brain.
    Henley JM; Mynlieff M; Lindstrom JM; Oswald RE
    Brain Res; 1986 Feb; 364(2):405-8. PubMed ID: 2418919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species- and subtype-specific recognition by antibody WF6 of a sequence segment forming an alpha-bungarotoxin binding site on the nicotinic acetylcholine receptor alpha subunit.
    McLane KE; Fritzen M; Wu X; Diethelm B; Maelicke A; Conti-Tronconi BM
    J Recept Res; 1992; 12(3):299-321. PubMed ID: 1507184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic acetylcholine receptor from chick optic lobe.
    Norman RI; Mehraban F; Barnard EA; Dolly JO
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1321-5. PubMed ID: 6175967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heterogeneity of acetylcholine receptor antibodies in patients with myasthenia gravis].
    Kalies I; Heinz F; Kaschka WP; Druschky KF; Kalden JR
    Klin Wochenschr; 1984 Apr; 62(8):377-85. PubMed ID: 6727277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic similarities between the hypothalamic alpha-bungarotoxin receptor and the Torpedo californica nicotinic cholinergic receptor.
    Block GA; Billiar RB
    Brain Res; 1979 Dec; 178(2-3):381-7. PubMed ID: 509210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that certain peripheral anti-acetylcholine receptor antibodies do not interact with brain BuTX binding sites.
    Morley BJ; Dwyer DS; Strang-Brown PF; Bradley RJ; Kemp GE
    Brain Res; 1983 Feb; 262(1):109-16. PubMed ID: 6831222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The isolation and characterisation of the nicotinic acetylcholine receptor from human skeletal muscle.
    Stephenson FA; Harrison R; Lunt GG
    Eur J Biochem; 1981 Mar; 115(1):91-7. PubMed ID: 7227375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to nicotinic acetylcholine receptors used to probe the structural and functional relationships between brain ?-bungarotoxin binding sites and nicotinic receptors.
    Mills A; Wonnacott S
    Neurochem Int; 1984; 6(2):249-57. PubMed ID: 20488045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of the alpha-bungarotoxin-binding regions on the extracellular part of the alpha-chain of Torpedo californica acetylcholine receptor.
    Mulac-Jericevic B; Atassi MZ
    Biochem J; 1987 Dec; 248(3):847-52. PubMed ID: 3435488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the alpha-bungarotoxin receptor in chick-embryo retina.
    Betz H
    Eur J Biochem; 1981 Jun; 117(1):131-9. PubMed ID: 7262081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties.
    Zouridakis M; Zisimopoulou P; Eliopoulos E; Poulas K; Tzartos SJ
    Biochim Biophys Acta; 2009 Feb; 1794(2):355-66. PubMed ID: 19059502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeled alpha-bungarotoxin derivatives: kinetic interaction with nicotinic acetylcholine receptors.
    Lukas RJ; Morimoto H; Hanley MR; Bennett EL
    Biochemistry; 1981 Dec; 20(26):7373-8. PubMed ID: 7326232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of a nicotinic acetylcholine receptor from chick brain.
    Whiting PJ; Lindstrom JM
    Biochemistry; 1986 Apr; 25(8):2082-93. PubMed ID: 3707934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic peptides used to locate the alpha-bungarotoxin binding site and immunogenic regions on alpha subunits of the nicotinic acetylcholine receptor.
    Ralston S; Sarin V; Thanh HL; Rivier J; Fox JL; Lindstrom J
    Biochemistry; 1987 Jun; 26(12):3261-6. PubMed ID: 2443159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoaffinity labeling of muscle-type nicotinic acetylcholine receptors and neuronal/nicotinic alpha-bungarotoxin binding sites with a derivative of alpha-bungarotoxin.
    Joy AM; Siegel HN; Lukas RJ
    Brain Res Mol Brain Res; 1993 Jan; 17(1-2):95-100. PubMed ID: 8381915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-bungarotoxin binding to a high molecular weight component from lower vertebrate brain identified on dodecyl sulfate protein-blots.
    Hawrot E; Wilson PT; Gershoni JM; Reese JH; Lentz TL
    Brain Res; 1986 May; 373(1-2):227-34. PubMed ID: 3719308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiochemical and immunological properties of acetylcholine receptors from human muscle.
    Kalies I; Heinz F; Hohlfeld R; Wekerle H; Birnberger KL; Kalden JR
    Mol Cell Biochem; 1984 Sep; 64(1):69-79. PubMed ID: 6493223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Bungarotoxin binding to the nicotinic acetylcholine receptor is inhibited by two distinct subpopulations of anti-receptor antibodies.
    Barkas T; Gairns JM; Kerr HJ; Coggins JR; Simpson JA
    Eur J Immunol; 1982 Sep; 12(9):757-61. PubMed ID: 7140813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Water-soluble acetylcholine receptor from Torpedo californica. Solubilization, purification and characterization.
    Kalderon N; Silman I
    Biochim Biophys Acta; 1977 Mar; 465(2):331-40. PubMed ID: 16250343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.